In 1991, The Cancer Therapy & Research Center (CTRC) at San Antonio launched its Institute for Drug Development (IDD) to find new treatments for patients with cancer through the integration of research programs of excellence in the translational and clinical sciences.

The IDD has been at the forefront of developing new cancer drugs for decades, with approximately 20 drugs approved by the U.S. Food and Drug Administration for cancer treatment. The program offers patients the opportunity to receive drugs that are only available here and that might not become available to cancer patients elsewhere for several years.